Delayed emesis: moderately emetogenic chemotherapy

  title={Delayed emesis: moderately emetogenic chemotherapy},
  author={Fausto Roila and David Warr and Rebecca Anne Clark-Snow and Maurizio Tonato and Richard J. Gralla and Lawrence Henry Einhorn and Jorn Herrstedt},
  journal={Supportive Care in Cancer},
Data on the incidence and efficacy of antiemetic prophylaxis against delayed emesis induced by moderately emetogenic chemotherapy are scanty. An overview of the literature has been done that showed the efficacy of dexamethasone in two of three randomized trials. Its optimal dose and duration of administration has not been defined. Only one of four randomized studies showed a statistically significant efficacy of 5-HT3 antagonists. Finally, only weak evidence has been published on the efficacy… CONTINUE READING
23 Citations
16 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 23 extracted citations


Publications referenced by this paper.
Showing 1-10 of 16 references

Cancer chemotherapy-induced delayed emesis: antiemetic prescriptions in clinical practice

  • V De Angelis, F Roila, R Sabbatini
  • Proc ASCO
  • 2003
1 Excerpt

Incidence and impact of nausea and vomiting with modern antiemetics: perception versus reality

  • SM Grunberg, M Hansen, R Deuson
  • Proc. ASCO 21:250a
  • 2002
1 Excerpt

Similar Papers

Loading similar papers…